Skip to main content

Cara Therapeutics Shares Jump On Licensing Deal For Pruritis Treatment

By: via Benzinga
Shares of Cara Therapeutics Inc (NASDAQ: CARA) are surging to a three-month high in reaction to a licensing agreement the biotech ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.